Rainbow Children's Medicare Ltd

Amaravati lease for pediatric hospital project

• Entered into a 60-year lease with APCRDA for approximately 2 acres in Amaravati.
• Leased land to be developed into a 250-bed super speciality children's hospital and perinatal care facility.
• Development to be executed in phases.
• Company will inform stock exchanges on progress; updates will be posted on the company's website.
• No investment amount disclosed in the filing.

Instrument Rated

• Issuer Rating: AA(Stable); reaffirmed by ICRA.

Rating Agency

• Agency: ICRA Limited.

Outlook

• Outlook: Stable.

Rationale

• Reaffirmation of the same rating as last time.
• No further rationale details provided.

Material Change

• Material change: rating reaffirmed; no change from prior rating.

Surveillance / Review

• Surveillance due within one year from rating communication date.
• Rating may be revised on new information or term changes.

Rainbow Children's Medicare Ltd – Trading Window shall remain closed from Oct 1, 2026; shall reopen 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended Sept 30, 2026.

ESOP grant details

• NRC approved grant of 55,690 stock options under ESOP 2025 on Sep 23, 2026.
• Options exercisable into 55,690 equity shares of ₹10 each (fully paid-up).
• Exercise price: discount up to 20% on latest NSE closing price as of Sep 22, 2026.
• Vesting: minimum one year; maximum ten years from grant; exercise window up to two years after vesting.
• Vested options: 5,387; exercised: 1,922; money realized: ₹23,94,812; resulting shares: 1,922.
• Options lapsed: 51,766 due to employee resignations.
• Compliance: ESOP 2025 complies with SEBI SBEB & SE Regulations, 2021.

KMPs authorised for materiality determinations

• Dr. Ramesh Kancharla, CMD, authorised to determine materiality and disclosures per Regulation 30(5) SEBI LODR.
• Mr. Abrarali Dalal, CEO, authorised to determine materiality and disclosures per Regulation 30(5) SEBI LODR.
• Mr. Sudarshan Patodia, CFO, authorised to determine materiality and disclosures per Regulation 30(5) SEBI LODR.
• Shreya Mitra, Secretary & Compliance Officer, authorised to determine materiality and disclosures under Regulation 30(5) SEBI LODR.

Key approvals

• Appointed Sudarshan Patodia as CFO and Group CFO, effective 23 September 2026.
• Approved amendments to the Policy on Determination of Materiality of Events/Information; amended policy available on the website.

Operational update

• Commenced operations of the 50-bed women's and children's hospital at Guntur, Andhra Pradesh.
• Follows earlier intimation dated July 29, 2026 regarding establishment.

Meeting Details

• September 18, 2026, full-day, in-person group meeting in Mumbai for Kotak Healthcare Forum 2026.
• September 21, 2026, full-day, in-person group meeting in Mumbai for Anand Rathi G-200 Summit 2026.
• September 22, 2026, full-day, in-person group meeting in Mumbai for J.P. Morgan Flagship India Conference.

Participants

• Company Secretary and Compliance Officer to attend on behalf of Rainbow Children's Medicare.

Purpose

• Intended for analyst/institutional investor engagement at scheduled events.

Additional Notes

• Schedule may change due to exigencies.
• No UPSI will be shared during engagements.

Resignation of Senior Management Personnel

• Srinath Metla, Chief Strategy and Growth Officer (SMP), resigned effective Sept 5, 2026 due to personal reasons.